Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 268.01%9.06B | 9.99%-18.89B | ---5.39B | -11.88%-20.98B | ---- | -468.40%-18.76B | ---- | 8.72%5.09B | ---- | 12.40%4.68B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 11.56%-613.31M | ---- | 13.15%-693.46M | ---- | 50.21%-798.44M | ---- | 17.74%-1.6B | ---- | 18.45%-1.95B |
| Dividend (income)- adjustment | ---- | ---2.34M | ---- | ---- | ---- | 34.65%-114.78M | ---- | 22.33%-175.64M | ---- | 2.67%-226.12M |
| Attributable subsidiary (profit) loss | ---- | -67.31%772.27M | ---- | 4.59%2.36B | ---- | 219.36%2.26B | ---- | -42.61%-1.89B | ---- | 23.04%-1.33B |
| Impairment and provisions: | ---- | -18.18%11.6B | ---- | 53.53%14.17B | ---- | 2,208.43%9.23B | ---- | 52.21%399.9M | ---- | -56.34%262.72M |
| -Other impairments and provisions | ---- | -18.18%11.6B | ---- | 53.53%14.17B | ---- | 2,208.43%9.23B | ---- | 52.21%399.9M | ---- | -56.34%262.72M |
| Revaluation surplus: | ---- | 39.11%2.31B | ---- | 218.04%1.66B | ---- | -13.97%523.25M | ---- | 284.20%608.19M | ---- | 45.18%-330.17M |
| -Fair value of investment properties (increase) | ---- | -19.56%746.51M | ---- | 262.34%928.02M | ---- | 301.05%256.12M | ---- | -59.07%63.86M | ---- | 141.79%156.05M |
| -Other fair value changes | ---- | 113.07%1.57B | ---- | 175.57%736.13M | ---- | -50.92%267.13M | ---- | 211.95%544.33M | ---- | -112.38%-486.22M |
| Asset sale loss (gain): | ---- | 153.58%538.6M | ---- | -188.31%-1.01B | ---- | 353.87%1.14B | ---- | -273.91%-448.38M | ---- | 126.85%257.83M |
| -Loss (gain) from sale of subsidiary company | ---- | -112.65%-15.2M | ---- | -82.48%120.13M | ---- | 287.14%685.77M | ---- | -208.29%-366.45M | ---- | 147.23%338.4M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -268.01%-11.53M | ---- | 1,114.03%6.87M | ---- | -126.34%-677K | ---- | 215.61%2.57M | ---- | -146.11%-2.22M |
| -Loss (gain) from selling other assets | ---- | 149.93%565.33M | ---- | -349.81%-1.13B | ---- | 636.35%453.23M | ---- | -7.86%-84.5M | ---- | 68.51%-78.35M |
| Depreciation and amortization: | ---- | 15.08%461.52M | ---- | 37.08%401.06M | ---- | 55.59%292.57M | ---- | 26.24%188.04M | ---- | -44.12%148.95M |
| -Depreciation | ---- | 42.42%181.32M | ---- | -0.95%127.32M | ---- | -13.43%128.54M | ---- | 141.55%148.49M | ---- | -36.22%61.47M |
| -Amortization of intangible assets | ---- | 35.35%117.24M | ---- | 1.91%86.62M | ---- | 178.04%85M | ---- | 221.95%30.57M | ---- | -43.67%9.5M |
| Financial expense | ---- | 2.03%3.59B | ---- | 14.71%3.52B | ---- | 36.96%3.07B | ---- | 6.05%2.24B | ---- | -11.81%2.11B |
| Exchange Loss (gain) | ---- | -68.12%70.16M | ---- | -81.32%220.11M | ---- | 438.20%1.18B | ---- | 71.29%-348.42M | ---- | -196.79%-1.21B |
| Special items | -376.50%-9.3B | -134.72%-494.3M | --3.36B | -46.07%1.42B | ---- | -45.00%2.64B | ---- | -15.35%4.8B | ---- | -13.47%5.67B |
| Operating profit before the change of operating capital | 87.81%-246.97M | -160.79%-655.49M | ---2.03B | 63.62%1.08B | ---- | -92.56%658.97M | ---- | 9.52%8.86B | ---- | 5.55%8.09B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 245.56%227.01M | ---- | 64.87%-155.96M | ---- | -300.44%-443.99M | ---- | -143.75%-110.88M | ---- | 169.05%253.45M |
| Developing property (increase)decrease | ---- | 87.25%-1.74B | ---- | -164.59%-13.66B | ---- | 25.49%21.15B | ---- | 266.61%16.85B | ---- | -198.85%-10.11B |
| Accounts receivable (increase)decrease | ---- | -148.39%-3.34B | ---- | 244.87%6.9B | ---- | 69.31%-4.76B | ---- | -681.69%-15.51B | ---- | 132.55%2.67B |
| Accounts payable increase (decrease) | ---- | 130.02%2.46B | ---- | 39.12%-8.2B | ---- | -275.02%-13.47B | ---- | -31.46%7.7B | ---- | 1,606.96%11.23B |
| Advance payment increase (decrease) | 175.27%3.17B | 54.96%-9.08B | ---4.21B | -33.40%-20.15B | ---- | -64.12%-15.11B | ---- | -183.36%-9.21B | ---- | 360.12%11.04B |
| Special items for working capital changes | -110.83%-748.98M | -66.92%13.2B | --6.91B | 2,088.71%39.91B | ---- | 127.53%1.82B | ---- | -130.93%-6.62B | ---- | -636.54%-2.87B |
| Cash from business operations | 220.88%2.17B | -81.09%1.08B | -86.40%677.4M | 156.29%5.72B | 300.67%4.98B | -620.97%-10.16B | -235.49%-2.48B | -90.40%1.95B | -58.14%1.83B | 250.31%20.3B |
| Other taxs | -804.97%-124.3M | 0.53%-535.55M | 98.01%-13.74M | 16.91%-538.42M | 50.17%-691.09M | 87.71%-647.99M | 47.98%-1.39B | -23.59%-5.27B | -26.23%-2.67B | -6.40%-4.26B |
| Interest paid - operating | 8.83%-449.6M | 55.51%-1.58B | 80.56%-493.17M | 24.91%-3.55B | -5.44%-2.54B | -2.23%-4.73B | 0.40%-2.41B | -0.14%-4.62B | -23.60%-2.42B | 9.29%-4.62B |
| Net cash from operations | 838.26%1.6B | -163.38%-1.03B | -90.28%170.5M | 110.50%1.63B | 127.95%1.75B | -95.50%-15.53B | -93.09%-6.27B | -169.58%-7.94B | -1,147.54%-3.25B | 445.66%11.42B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -84.24%39.3M | ---- | -83.57%249.41M | ---- | -28.45%1.52B | ---- | 8.82%2.12B | ---- | -18.45%1.95B |
| Dividend received - investment | --584.92M | 120.87%229.43M | ---- | -55.78%103.87M | ---- | -89.05%234.92M | ---- | 369.85%2.15B | ---- | -50.88%456.61M |
| Loan receivable (increase) decrease | -115.52%-32.17M | -39.74%5.4B | -86.22%207.26M | -84.22%8.96B | 29.46%1.5B | -19.82%56.79B | 119.53%1.16B | -36.99%70.83B | -229.65%-5.95B | 5,008.77%112.41B |
| Sale of fixed assets | ---- | -74.45%18.81M | ---- | -27.88%73.65M | ---- | 831.82%102.12M | ---- | -37.24%10.96M | ---- | -21.53%17.46M |
| Purchase of fixed assets | ---- | 21.23%-136.47M | ---- | 45.97%-173.27M | ---- | -20.71%-320.66M | ---- | 55.48%-265.64M | ---- | -8.22%-596.68M |
| Purchase of intangible assets | ---- | -30.19%-14.44M | ---- | 87.57%-11.09M | ---- | -180.08%-89.19M | ---- | 31.00%-31.84M | ---- | 65.18%-46.15M |
| Sale of subsidiaries | ---- | -32.53%3.39B | ---- | 117.21%5.02B | ---- | 16.71%2.31B | ---- | 1,520.41%1.98B | ---- | -108.16%-139.49M |
| Acquisition of subsidiaries | ---- | 144.25%173.45M | ---- | -851.22%-391.94M | ---- | -113.75%-41.2M | ---- | -115.80%-19.28M | ---- | 98.02%-8.93M |
| Recovery of cash from investments | ---- | 253.73%147.36M | ---- | -96.90%41.66M | ---- | 270.95%1.34B | ---- | -37.49%362.1M | ---- | 317.63%579.3M |
| Cash on investment | 82.28%-50.07M | 17.95%-6.12B | -219.38%-282.47M | 86.54%-7.45B | 79.20%-88.44M | 38.34%-55.38B | 71.07%-425.17M | 20.06%-89.82B | -189.99%-1.47B | -1,674.89%-112.35B |
| Other items in the investment business | 13.76%417.32M | 302.12%359.82M | -90.02%366.85M | --89.48M | 117.33%3.67B | ---- | -4.49%1.69B | ---- | -52.02%1.77B | ---- |
| Net cash from investment operations | 215.45%920M | -46.42%3.49B | -94.27%291.65M | 0.58%6.51B | 109.69%5.09B | 151.02%6.47B | 142.97%2.43B | -657.74%-12.68B | -172.69%-5.65B | 149.82%2.27B |
| Net cash before financing | 445.23%2.52B | -69.84%2.45B | -93.25%462.15M | 189.85%8.14B | 277.91%6.84B | 56.08%-9.06B | 56.77%-3.85B | -250.66%-20.63B | -210.11%-8.9B | 274.03%13.69B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -89.15%78.77M | -79.04%1.42B | -87.70%725.74M | -78.31%6.77B | -68.26%5.9B | -41.99%31.19B | -37.45%18.59B | 35.94%53.77B | 59.52%29.72B | -1.23%39.55B |
| Refund | -118.84%-2.43B | 79.00%-3.42B | 91.67%-1.11B | 51.76%-16.28B | 36.81%-13.33B | 34.31%-33.74B | 20.84%-21.09B | -14.24%-51.36B | -68.25%-26.64B | 2.20%-44.96B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 6.59%3.38B |
| Dividends paid - financing | ---- | 55.71%-245.8M | ---- | 63.78%-554.99M | ---- | 16.56%-1.53B | ---- | -43.45%-1.84B | ---- | 46.09%-1.28B |
| Absorb investment income | ---- | -99.39%665K | ---- | 2,744.65%108.38M | ---- | -99.88%3.81M | ---- | 77.60%3.1B | ---- | -61.15%1.74B |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | -20,685.44%-2.01B | ---- | 34.91%-9.65M | ---- | -1,339.90%-14.83M |
| Other items of the financing business | 78.64%-77.03M | 82.91%-98.6M | 58.18%-360.56M | 68.12%-577.08M | -86.62%-862.07M | -443.30%-1.81B | 1.50%-461.95M | 91.01%-333.17M | -569.03%-469M | -5,994.43%-3.71B |
| Net cash from financing operations | -225.94%-2.43B | 76.40%-2.54B | 91.02%-744.59M | -35.03%-10.77B | -180.18%-8.29B | -347.57%-7.98B | -213.05%-2.96B | 160.06%3.22B | -4.16%2.62B | -670.86%-5.37B |
| Effect of rate | -183.48%-2.23M | 759.44%4.64M | 107.78%2.68M | -88.07%540K | 85.40%-34.36M | 106.45%4.53M | -600.76%-235.31M | 71.82%-70.2M | -200.24%-33.58M | -160.93%-249.11M |
| Net Cash | 132.86%92.81M | 96.67%-87.72M | 80.43%-282.44M | 84.53%-2.63B | 78.79%-1.44B | 2.11%-17.04B | -8.32%-6.8B | -309.07%-17.4B | -158.11%-6.28B | 197.21%8.32B |
| Begining period cash | -4.18%1.91B | -56.98%1.99B | -56.98%1.99B | -78.65%4.62B | -78.65%4.62B | -44.66%21.66B | -44.66%21.66B | 26.00%39.13B | 26.00%39.13B | -20.80%31.05B |
| Cash at the end | 16.81%2B | -4.18%1.91B | -45.67%1.71B | -56.98%1.99B | -78.48%3.15B | -78.65%4.62B | -55.46%14.62B | -44.66%21.66B | -21.69%32.81B | 26.00%39.13B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.